Boehmelt, Guido
Boehringer Ingelheim (Austria)
3 papers on CoChatORCID 0000-0001-6636-0832
Most cited papers
- Verified
BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
Farnaby, W., Koegl, M., Roy, M. J., Whitworth, C., Diers, E., Trainor, N., Zollman, D., Steurer, S., Karolyi-Oezguer, J., Riedmueller, C., et al. (2019) · Nature Chemical Biology
Protein Degradation and InhibitorsChromatin Remodeling and Cancer
Cited by 562
- Verified
BacPROTACs mediate targeted protein degradation in bacteria
Morreale, F. E., Kleine, S., Leodolter, J., Junker, S., Hoi, D. M., Ovchinnikov, S., Okun, A., Kley, J., Kurzbauer, R., Junk, L., et al. (2022) · Cell
Protein Degradation and InhibitorsHeat shock proteins research
Cited by 196
- Verified
Discovery and characterization of brigimadlin, a novel and highly potent MDM2-p53 antagonist suitable for intermittent dose schedules
Gollner, A., Rudolph, D., Weyer-Czernilofsky, U., Baumgartinger, R., Jung, P., Weinstabl, H., Ramharter, J., Grempler, R., Quant, J., Rinnenthal, J., et al. (2024) · Molecular Cancer Therapeutics
Cancer-related Molecular PathwaysCancer Mechanisms and Therapy
Cited by 18
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free